-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 AVnsqamWSIQE/mouFA60eY9jmyEAKGtYou0aXp+Oiqbpf6O3gUKPcKRImrZKtRnl
 se0NWeJACZByewjTvz5JIA==

<SEC-DOCUMENT>0000950123-09-020940.txt : 20090708
<SEC-HEADER>0000950123-09-020940.hdr.sgml : 20090708
<ACCEPTANCE-DATETIME>20090708172613
ACCESSION NUMBER:		0000950123-09-020940
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20090708
DATE AS OF CHANGE:		20090708

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Burlingame Seamus P.
		CENTRAL INDEX KEY:			0001468024

	FILING VALUES:
		FORM TYPE:		SC 13D

	MAIL ADDRESS:	
		STREET 1:		3546 N. RIVERSIDE AVENUE
		CITY:			RIALTO
		STATE:			CA
		ZIP:			92377

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Oculus Innovative Sciences, Inc.
		CENTRAL INDEX KEY:			0001367083
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				680423298
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-84019
		FILM NUMBER:		09935654

	BUSINESS ADDRESS:	
		STREET 1:		1129 N. MCDOWELL BLVD.
		CITY:			PETALUMA
		STATE:			CA
		ZIP:			94954
		BUSINESS PHONE:		707-782-0792

	MAIL ADDRESS:	
		STREET 1:		1129 N. MCDOWELL BLVD.
		CITY:			PETALUMA
		STATE:			CA
		ZIP:			94954
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<FILENAME>f52937asc13d.htm
<DESCRIPTION>SC 13D
<TEXT>
<HTML>
<HEAD>
<TITLE>sc13d</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>SCHEDULE 13D</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>Under the Securities Exchange Act of 1934</B>
</DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B><FONT style="border-bottom: 1px solid #000000">Oculus Innovative Sciences, Inc.</FONT></B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Name of Issuer)</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Common Stock</DIV>

<DIV align="center" style="font-size: 10pt"><DIV style="margin-top: 1px"><FONT style="border-top: 1px solid #000000">(Title of Class of Securities)</FONT></DIV></DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 12pt">67575P10</DIV>

<DIV align="center" style="font-size: 10pt"><DIV style="margin-top: 1px"><FONT style="border-top: 1px solid #000000">(CUSIP Number)</FONT></DIV></DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Hojabr Alimi<BR>
Chief Executive Officer<BR>
Oculus Innovative Sciences, Inc.<BR>
1129 N. McDowell Blvd.<BR>
Petaluma, CA 94954<BR>
707-782-0792</DIV>

<DIV align="center" style="font-size: 10pt"><DIV style="margin-top: 1px"><FONT style="border-top: 1px solid #000000">(Name, Address and Telephone Number of Person Authorized to</FONT></DIV></DIV>


<DIV align="center" style="font-size: 10pt">Receive Notices and Communications)</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 12pt">June&nbsp;1, 2009</DIV>

<DIV align="center" style="font-size: 10pt"><DIV style="margin-top: 1px"><FONT style="border-top: 1px solid #000000">(Date of Event Which Requires Filing of This Statement)</FONT></DIV></DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">If the filing person has previously filed a statement on Schedule&nbsp;13G to report the
acquisition that is the subject of this Schedule&nbsp;13D, and is filing this schedule because
of &#167;&#167;240.13d-1(e), 240.13d-1(f) or 240.13d(g), check the following box.&nbsp;&nbsp;&nbsp;&nbsp; <FONT face="Wingdings">&#111;</FONT>
</DIV>


<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">








<!--TOC-->
<!--/TOC-->





<DIV align="left" style="font-size: 10pt; margin-top: 12pt">CUSIP No.&nbsp;67575P10
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>(1)&nbsp;Name of reporting person</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Mr.&nbsp;Seamus P. Burlingame

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>(2)&nbsp;Check the appropriate box if a member of a group</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="Wingdings">&#111;</FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="Wingdings">&#111;</FONT>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>(3)&nbsp;SEC USE ONLY</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>(4)&nbsp;Source of funds</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">PF
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>(5)&nbsp;Check if disclosure of legal proceedings is required pursuant to Items 2(d) or
2(e)</B>&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="Wingdings">&#111;</FONT>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>(6)&nbsp;Citizenship or place of organization</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The reporting person is a citizen of the United States of America.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>Number of shares beneficially owned by each reporting person with:</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>(7)&nbsp;Sole voting power:</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The reporting person has sole voting power over 1,580,504 shares he beneficially owns.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>(8)&nbsp;Shared voting power:</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The reporting person does not share voting power over any shares he beneficially owns.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>(9)&nbsp;Sole dispositive power:</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The reporting person has sole dispositive power over 1,580,504 shares he beneficially
owns.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>(10)&nbsp;Shared dispositive power:</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The reporting person does not share dispositive power over any shares he beneficially
owns.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>(11)&nbsp;Aggregate amount beneficially owned by each reporting person:</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Seamus P. Burlingame: 1,580,504 shares. As of the date of filing of this Schedule&nbsp;13D, the
reporting person&#146;s beneficial ownership is comprised of 1,580,504 shares of common stock.
Additionally, the reporting person owns warrants as described below.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">On September&nbsp;4, 2009, 333,333 and 444,445 shares of common stock underlying Series&nbsp;A
and Series&nbsp;B Warrants issued March&nbsp;4, 2009, respectively, will become exercisable
pursuant to the terms of those warrants. On December&nbsp;1, 2009, 666,667 and 888,888 shares
of common stock
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">underlying Series&nbsp;A and Series&nbsp;B Warrants issued June&nbsp;1, 2009, respectively, will become
exercisable pursuant to the terms of those warrants. The aggregate number of shares of
common stock into which such warrants are exercisable, and which the reporting person has
the right to acquire beneficial ownership, is limited to the number of shares of common
stock that, together with all other shares of common stock beneficially owned by the
reporting person does not exceed 4.99% of the total issued and outstanding shares of common
stock of the Issuer. Additionally, the common shares underlying the Series&nbsp;A and Series&nbsp;B
Warrants issued on June&nbsp;1, 2009, may not be acquired within 60&nbsp;days until October&nbsp;2, 2009.
Therefore, the reporting person is not including these shares in the calculation of
beneficial ownership as of the date of this filing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>(12)&nbsp;Check Box if the Aggregate Amount in Row (11)&nbsp;Excludes Certain Shares&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="Wingdings">&#111;</FONT></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>(13)&nbsp;Percent of Class&nbsp;Represented by Amount in Row (11): </B>Based on 20,572,619 shares
of common stock outstanding as of July&nbsp;6, 2009:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">7.7%
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>(14)&nbsp;Type of Reporting Person</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">IN
</DIV>

<!-- link2 "Item&nbsp;1: Security and Issuer" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;1: Security and Issuer</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This Schedule&nbsp;13D relates to the beneficial ownership of common stock of the Issuer
whose principal executive office is located at 1129 N. McDowell Blvd., Petaluma, CA
94954.
</DIV>

<!-- link2 "Item&nbsp;2: Identity and Background" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;2: Identity and Background</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.&nbsp;Seamus P. Burlingame
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.&nbsp;c/o Burlingame Industries, Inc., 3546 N. Riverside Avenue, Rialto, CA 92377
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.&nbsp;The reporting person is the Chief Operating Officer of Burlingame Industries,
Inc., a manufacturer of concrete roof tile. The principal place of business of
Burlingame Industries, Inc. is 3546 N. Riverside Avenue, Rialto, CA 92377.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.&nbsp;During the last 5&nbsp;years, the reporting person has not been convicted in any
criminal proceeding.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e.&nbsp;During the last 5&nbsp;years, the reporting person has not been a party to a civil
proceeding before a judicial or administrative body of competent jurisdiction resulting
in a judgment, decree or final order enjoining future violation of, prohibiting or
mandating activities subject to, federal or state securities laws or finding any
violation with respect to such laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f.&nbsp;The reporting person is a citizen of the United States of America.
</DIV>
<!-- link2 "Item&nbsp;3: Source and Amount of Funds or Other Consideration" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;3: Source and Amount of Funds or Other Consideration</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">On October&nbsp;31, 2003, the Issuer granted the reporting person 4,166 shares of Series&nbsp;A
Preferred Stock that were converted to 4,166 shares of common stock upon completion of
the Issuer&#146;s
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"> initial public offering on January&nbsp;24, 2007. These shares were issued in exchange for cash
consideration of $25,000. On March&nbsp;21, 2007, the Issuer granted the reporting person 270
shares of common stock. The shares were issued as a dividend on the Series&nbsp;A Preferred
Stock.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">On February&nbsp;24, 2009, the reporting person and an accredited investor (together, the
&#147;Investors&#148;), entered into a purchase agreement, dated February&nbsp;24, 2009 (the &#147;Purchase
Agreement&#148;) with the Issuer. Pursuant to the terms of the Purchase Agreement, the
Investors agreed to invest a total of $3,000,000 in exchange for a total of 2,564,103
shares of the Issuer&#146;s common stock issuable to the Investors, or their designee, in two
tranches, pro rata to the investment amounts paid by the Investors on each date the
Investors provided funds (each a &#147;Closing Date&#148;). In addition, the Issuer agreed to issue
to the Investors Series&nbsp;A Warrants to purchase a total of 1,500,000 shares of common
stock pro rata to the number of shares of common stock issued on each Closing Date. The
Issuer also agreed to issue to the Investors Series&nbsp;B Warrants to purchase a total of
2,000,000 shares of common stock pro rata to the number of shares of common stock issued
on each Closing Date. The Investors paid $1,000,000 on February&nbsp;24, 2009 and the
remaining $2,000,000 on June&nbsp;1, 2009.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In exchange for the initial investment made on February&nbsp;24, 2009, the reporting person
received 436,467 shares of common stock, a Series&nbsp;A Warrant to purchase 333,333 shares of
common stock and a Series&nbsp;B Warrant to purchase 444,445 shares of common stock. On the
second Closing Date, June&nbsp;1, 2009, the reporting person received 1,139,601 shares of
common stock, a Series&nbsp;A Warrant to purchase 666,667 shares of common stock and a Series
B Warrant to purchase 888,888 shares of common stock.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">On December&nbsp;15, 2006, the Issuer effected a 1-for-4 reverse split of its common stock
and convertible preferred stock. All common and convertible preferred shares and per
share amounts herein have been adjusted to reflect this reverse split.
</DIV>

<!-- link2 "Item&nbsp;4: Purpose of Transaction" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;4: Purpose of Transaction</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">See Item&nbsp;3, above. The reporting person, as described in Item&nbsp;3, purchased the
securities for the purpose of acquiring an investment in the Issuer.
</DIV>

<!-- link2 "Item&nbsp;5: Interest in Securities of the Issuer" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;5: Interest in Securities of the Issuer</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.&nbsp;The reporting person is the beneficial owner of 1,580,504 shares or 7.7% of the
common stock issued and outstanding of the Issuer. All of these shares are owned
outright.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.&nbsp;The reporting person has sole voting and dispositive power over 1,580,504 shares
of common stock of the Issuer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.&nbsp;The reporting person effected the following transactions with respect to the
common stock of the Issuer during the past 60&nbsp;days:
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">On June&nbsp;1, 2009, the second Closing Date of a private placement described in Item&nbsp;3,
the reporting person acquired 1,139,601 shares of common stock, a Series&nbsp;A Warrant to
purchase 666,667 shares of common stock and a Series&nbsp;B Warrant to purchase 888,888 shares
of common stock in connection with the Purchase Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.&nbsp;N/A
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e.&nbsp;N/A
</DIV>
<!-- link2 "Item&nbsp;6: Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;6: Contracts, Arrangements, Understandings or Relationships With Respect to
Securities of the Issuer.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The reporting person and the Issuer are parties to a Purchase Agreement, dated February
24, 2009, pursuant to which the Issuer agreed to issue common stock and warrants, as
described elsewhere in this Schedule&nbsp;13D, in exchange for an investment in the Issuer.
</DIV>

<!-- link2 "Item&nbsp;7: Material to be Filed as Exhibits" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;7: Material to be Filed as Exhibits.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">None.

</DIV>
<!-- link1 "SIGNATURE" -->

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;After reasonable inquiry and to the best of my knowledge and belief, I certify that the
information set forth in this statement is true, complete and correct.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Date: July&nbsp;8, 2009
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="35%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="60%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Seamus P. Burlingame
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
By: Seamus P. Burlingame
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
